Thor Medical Stock Börse Stuttgart
Stocks
8NN
NO0010597883
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Börse Stuttgart
23:55:18 31/08/2026 +04
|
5-day change | 1st Jan Change | ||
| 0.5250 EUR | -3.67% |
|
-11.09% | +28.54% |
| 08-28 | Thor Medical ASA Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 08-28 | Thor Medical ASA, H1 2026 Earnings Call, Aug 28, 2026 |
| Market Cap | 2.04B 219M 188M 177M 162M 301M 20.83B 306M 2.09B 816M 10.57B 822M 804M 34.89B | P/E 2026 * |
-40.6x | P/E 2027 * | -51.6x |
|---|---|---|---|---|---|
| Enterprise Value | 2.23B 239M 205M 193M 176M 328M 22.69B 333M 2.28B 889M 11.51B 895M 876M 38.01B | EV / Sales 2026 * |
45.5x | EV / Sales 2027 * | 13.2x |
| Free-Float |
59.77% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript : Thor Medical
| 1 week | -19.48% | ||
| Current month | -0.76% | ||
| 1 month | -0.76% | ||
| 3 months | +24.56% | ||
| 6 months | +41.51% | ||
| Current year | +23.82% |
| 1 week | 0.52 |  | 0.66 |
| 1 month | 0.46 | | 0.66 |
| 3 years | 0.05 | | 0.66 |
| 5 years | 0.04 | | 3.03 |
| 10 years | 0.04 | | 13.39 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jasper Kurth
CEO | Chief Executive Officer | 41 | 01/08/2024 |
| Director of Finance/CFO | 37 | 01/07/2023 | |
Sindre Hassfjell
CTO | Chief Tech/Sci/R&D Officer | - | 01/06/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 67 | 28/06/2023 | |
John Andersen
CHM | Chairman | 59 | - |
| Director/Board Member | - | 24/04/2025 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.67% | -11.09% | +112.98% | +406.76% | 231M | |
| -1.66% | -4.96% | +49.84% | +88.43% | 69.54B | |
| -2.19% | +1.32% | +44.54% | +88.38% | 64.97B | |
| -3.57% | -4.24% | +47.11% | +5.60% | 26.51B | |
| +2.77% | -1.74% | -16.16% | +456.51% | 25.89B | |
| -0.46% | -9.94% | +0.98% | -15.98% | 25.64B | |
| -9.71% | -0.36% | +245.87% | +377.68% | 20.22B | |
| -1.58% | +0.47% | +29.35% | -19.62% | 19.98B | |
| -3.36% | -7.58% | +9.47% | +535.81% | 15.69B | |
| +0.35% | +0.16% | +46.96% | +144.04% | 13.49B | |
| Average | -2.16% | -3.70% | +57.09% | +206.76% | 31.33B | |
| Weighted average by Cap. | -2.02% | -3.50% | +48.13% | +145.78% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 49M 5.25M 4.52M 4.24M 3.87M 7.22M 499M 7.32M 50.18M 19.54M 253M 19.7M 19.27M 836M | 168M 17.99M 15.49M 14.54M 13.28M 24.75M 1.71B 25.1M 172M 67M 868M 67.53M 66.06M 2.87B |
| Net income | -49M -5.25M -4.52M -4.24M -3.87M -7.22M -499M -7.32M -50.18M -19.54M -253M -19.7M -19.27M -836M | -40M -4.28M -3.69M -3.46M -3.16M -5.89M -407M -5.98M -40.97M -15.95M -207M -16.08M -15.73M -682M |
| Net Debt | 183M 19.59M 16.87M 15.83M 14.47M 26.96M 1.86B 27.34M 187M 72.99M 946M 73.56M 71.96M 3.12B | 177M 18.95M 16.32M 15.31M 13.99M 26.07M 1.8B 26.44M 181M 70.59M 915M 71.15M 69.6M 3.02B |
Employees
-
| Date | Price | Change |
|---|---|---|
| 31/08/26 | €0.5250 | -3.67% |
| 28/08/26 | €0.5450 | -11.81% |
| 27/08/26 | €0.6180 | -2.52% |
| 26/08/26 | €0.6340 | +2.92% |
| 25/08/26 | €0.6160 | -5.52% |
Sell
Buy
Mean consensus
SELL
Number of Analysts
1
Last Close Price
5.680NOK
Average target price
3.500NOK
Spread / Average Target
-38.38%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- NANOV Stock
- 8NN Stock
Select your edition
All financial news and data tailored to specific country editions
